Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Effects of lamotrigine on attention-deficit hyperactivity disorder in pediatric epilepsy patients

  • Han, Seung-A (Department of Pediatrics, Chonbuk National University Medical School) ;
  • Yang, Eu Jeen (Department of Pediatrics, Pusan National University Children's Hospital) ;
  • Song, Mi-Kyoung (Department of Pediatrics, Chonbuk National University Medical School) ;
  • Kim, Sun Jun (Department of Pediatrics, Chonbuk National University Medical School)
  • Received : 2016.12.30
  • Accepted : 2017.04.11
  • Published : 2017.06.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: The purpose of this study was to investigate the effects of lamotrigine for the treatment of attention-deficit hyperactivity disorder (ADHD) symptoms in children with epilepsy. Methods: Pediatric patients newly diagnosed with epilepsy (n=90 [61 boys and 29 girls]; mean age, $9.1{\pm}3.4years$) were enrolled. All patients were evaluated with the Korean ADHD rating scale (K-ARS)-IV before treatment with lamotrigine and after doses had been administered. The mean interval of ADHD testing was approximately 12.3 months. The initial dosage of lamotrigine was 1 mg/kg/day (maximum 25 mg/day for the first 2 weeks), and increased by 1 mg/kg every 2 weeks until titrated up to 7 mg/kg/day (or maximum 200 mg/day). Results: The mean ADHD test score of the 90 subjects was $17.0{\pm}1.8$ at baseline. It was slightly reduced to $15.6{\pm}1.7$ after lamotrigine monotherapy (P>0.01). Prior to treatment, a total of 31 patients (34.4%) met the diagnostic criteria for ADHD according to Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision, Of these 31 patients, 27 (87.1%) had significantly improved ADHD scores with lamotrigine monotherapy ($28.0{\pm}1.6$ reduced to $18.1{\pm}2.6$, P<0.001). Among these 27 patients, 25 (92.6%) showed normalized electroencephalogram (EEG) and 26 (96.3%) achieved total freedom from seizures within 12 months of the initiation of lamotrigine monotherapy. Conclusion: The results from our study show that lamotrigine had a positive effect in pediatric epilepsy patients by reducing ADHD symptoms, preventing seizures, and normalizing EEG. However, further research is required to determine whether lamotrigine is efficacious against ADHD symptoms independent of its effects on epileptic seizures.

Keywords

References

  1. Gucuyener K, Erdemoglu AK, Senol S, Serdaroglu A, Soysal S, Kockar AI. Use of methylphenidate for attention-deficit hyperactivity disorder in patients with epilepsy or electroencephalographic abnormalities. J Child Neurol 2003;18:109-12. https://doi.org/10.1177/08830738030180020601
  2. Bennett-Back O, Keren A, Zelnik N. Attention-deficit hyperactivity disorder in children with benign epilepsy and their siblings. Pediatr Neurol 2011;44:187-92. https://doi.org/10.1016/j.pediatrneurol.2010.10.003
  3. Cohen R, Senecky Y, Shuper A, Inbar D, Chodick G, Shalev V, et al. Prevalence of epilepsy and attention-deficit hyperactivity (ADHD) disorder: a population-based study. J Child Neurol 2013;28:120-3. https://doi.org/10.1177/0883073812440327
  4. Pellock JM. The challenge of neuropsychiatric issues in pediatric epilepsy. J Child Neurol 2004;19 Suppl 1:S1-5.
  5. Morton WA, Stockton GG. Methylphenidate Abuse and psychiatric side effects. Prim Care Companion J Clin Psychiatry 2000;2:159-64. https://doi.org/10.4088/PCC.v02n0502
  6. Trimble MR, Cull C. Children of school age: the influence of antiepileptic drugs on behavior and intellect. Epilepsia 1988;29 Suppl 3:S15-9.
  7. Uvebrant P, Bauziene R. Intractable epilepsy in children. The efficacy of lamotrigine treatment, including non-seizure-related benefits. Neuropediatrics 1994;25:284-9. https://doi.org/10.1055/s-2008-1073041
  8. Park JI, Shim SH, Lee M, Jung YE, Park TW, Park SH, et al. The validities and efficiencies of Korean ADHD rating scale and Korean child behavior checklist for screening children with ADHD in the community. Psychiatry Investig 2014;11:258-65. https://doi.org/10.4306/pi.2014.11.3.258
  9. Oncu B, Er O, Colak B, Nutt DJ. Lamotrigine for attention deficithyperactivity disorder comorbid with mood disorders: a case series. J Psychopharmacol 2014;28:282-3. https://doi.org/10.1177/0269881113493365
  10. Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. American Academy of Pediatrics. Pediatrics 2000;105:1158-70. https://doi.org/10.1542/peds.105.5.1158
  11. Choi HY, Han JY, Kim SJ, Eom TH, Bin JH, Kim YH, et al. Characteristics of children with epilepsy and concomitant attentiondeficit hyperactivity disorder. J Korean Child Neurol Soc 2013;21:162-9.
  12. Stores G, Hart J, Piran N. Inattentiveness in schoolchildren with epilepsy. Epilepsia 1978;19:169-75. https://doi.org/10.1111/j.1528-1157.1978.tb05027.x
  13. Hesdorffer DC, Ludvigsson P, Olafsson E, Gudmundsson G, Kjartansson O, Hauser WA. ADHD as a risk factor for incident unprovoked seizures and epilepsy in children. Arch Gen Psychiatry 2004;61:731-6. https://doi.org/10.1001/archpsyc.61.7.731
  14. Cheung H, Kamp D, Harris E. An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels. Epilepsy Res 1992;13:107-12. https://doi.org/10.1016/0920-1211(92)90065-2
  15. Han JH, Oh JE, Kim SJ. Clinical efficacy and safety of lamotrigine monotherapy in newly diagnosed pediatric patients with epilepsy. Korean J Pediatr 2010;53:565-9. https://doi.org/10.3345/kjp.2010.53.4.565
  16. Sim GY, Son JW, Kim WS. The comorbidity of attention deficit hyperactivity disorder in children with epilepsy. J Korean Child Neurol Soc 2012;20:129-36.
  17. Semrud-Clikeman M, Wical B. Components of attention in children with complex partial seizures with and without ADHD. Epilepsia 1999;40:211-5. https://doi.org/10.1111/j.1528-1157.1999.tb02077.x
  18. Williams J, Griebel ML, Dykman RA. Neuropsychological patterns in pediatric epilepsy. Seizure 1998;7:223-8. https://doi.org/10.1016/S1059-1311(98)80040-X
  19. Davids E, Kis B, Specka M, Gastpar M. A pilot clinical trial of oxcarbazepine in adults with attention-deficit hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry 2006;30:1033-8. https://doi.org/10.1016/j.pnpbp.2006.03.035

Cited by

  1. The Challenge of Pharmacotherapy in Children and Adolescents with Epilepsy-ADHD Comorbidity vol.38, pp.1, 2018, https://doi.org/10.1007/s40261-017-0585-1